Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 16

1.

In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.

Ma L, Yu P, Veerendra B, Rold TL, Retzloff L, Prasanphanich A, Sieckman G, Hoffman TJ, Volkert WA, Smith CJ.

Mol Imaging. 2007 May-Jun;6(3):171-80.

PMID:
17532883
2.

Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).

Biddlecombe GB, Rogers BE, de Visser M, Parry JJ, de Jong M, Erion JL, Lewis JS.

Bioconjug Chem. 2007 May-Jun;18(3):724-30. Epub 2007 Mar 23.

PMID:
17378600
3.

Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.

de Visser M, Bernard HF, Erion JL, Schmidt MA, Srinivasan A, Waser B, Reubi JC, Krenning EP, de Jong M.

Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1228-38. Epub 2007 Feb 8.

PMID:
17287960
4.

Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.

Ferro-Flores G, Arteaga de Murphy C, Rodriguez-Cortés J, Pedraza-López M, Ramírez-Iglesias MT.

Nucl Med Commun. 2006 Apr;27(4):371-6.

PMID:
16531924
5.

18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.

Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, Xing L, Chen X.

J Nucl Med. 2006 Mar;47(3):492-501.

6.

Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.

Smith CJ, Volkert WA, Hoffman TJ.

Nucl Med Biol. 2005 Oct;32(7):733-40. Review.

PMID:
16243649
7.

microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.

Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS.

J Nucl Med. 2004 Aug;45(8):1390-7.

8.

Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.

Smith CJ, Volkert WA, Hoffman TJ.

Nucl Med Biol. 2003 Nov;30(8):861-8. Review.

PMID:
14698790
9.

[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.

Nock B, Nikolopoulou A, Chiotellis E, Loudos G, Maintas D, Reubi JC, Maina T.

Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):247-58. Epub 2002 Nov 29.

PMID:
12552343
10.
11.

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

Breeman WA, de Jong M, Erion JL, Bugaj JE, Srinivasan A, Bernard BF, Kwekkeboom DJ, Visser TJ, Krenning EP.

J Nucl Med. 2002 Dec;43(12):1650-6.

12.
13.

Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy.

Breeman WA, De Jong M, Bernard BF, Kwekkeboom DJ, Srinivasan A, van der Pluijm ME, Hofland LJ, Visser TJ, Krenning EP.

Int J Cancer. 1999 Nov 26;83(5):657-63.

14.

Studies on radiolabeled somatostatin analogues in rats and in patients.

Breeman WA, Bakker WH, De Jong M, Hofland LJ, Kwekkeboom DJ, Kooij PP, Visser TJ, Krenning EP.

Q J Nucl Med. 1996 Sep;40(3):209-20. Review.

PMID:
8961800
15.

Expression and characterization of cloned human bombesin receptors.

Benya RV, Kusui T, Pradhan TK, Battey JF, Jensen RT.

Mol Pharmacol. 1995 Jan;47(1):10-20.

PMID:
7838118
16.

Supplemental Content

Support Center